Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
I can imagine, so sorry about the damages. I wouldn't sleep either. Wishing you strength, courage and lots of helping hands!
Cheers
Good morning early bird
HTM I am still holding from 0.40. I play this one each quarter.
AVL on watch for b/o 0.62
KIPS nice little momentum
MSTX time to make a move to $1.24 then
MSTX yes, it reads nice. Any well written article that highlights this company is good for me. Trial results and partnership will eventually raise the pps imo.
Cheers
HTM wants to go I think
KIPS she does look good indeed
KIPS Announces the First Austrian Implant of the eSVS Mesh
MSTX Acquires Aires Pharmaceuticals, Inc
The acquisition of Aires will enhance our pipeline with a phase 2 asset with more than 120 human subject exposures and which is a strategic complement to our lead program, MST-188. With total consideration of approximately 6% of Mast equity, it represents excellent value for our stockholders," stated Brian M. Culley , Chief Executive Officer of Mast Therapeutics, Inc.
"Another highlight of this acquisition is its favorable economics. Aires had completed several venture financings, including a $20 million Series B round.
We are paying significantly less than that to acquire the program and we currently estimate that our development costs for AIR001 for the first 12 months will be approximately $2million. Our estimated costs for AIR001 will change as we refine our development strategy over the next few months, but Aires is expected to contribute approximately $3 million of net cash at the closing of the merger, so, as currently contemplated, our first year of development of AIR001 will not require additional capital investment by Mast," Mr. Culley concluded.
Under the terms of the all-stock transaction, Aires would become a wholly-owned subsidiary of Mast Therapeutics, Inc. in exchange for shares of Mast common stock representing approximately 6% of Mast's outstanding common stock, 80% of which would be subject to a six-month holdback for certain indemnification claims of Mast. There are no milestone obligations payable to Aires. The acquisition is expected to close in February 2014 , subject to customary closing conditions.
KIPS here she goes guys! Good buying
MSTX Looking good going into next week.
https://www.federalregister.gov/articles/2013/11/06/2013-26548/sickle-cell-disease-public-meeting-on-patient-focused-drug-development
Sure sounds like fun! Enjoy!
KIPS looks like she wants to go... hopefully
QTM it is a fine chart as I mentioned it last week. Unfortunately I had to sell for 0.03 loss cause she won't move.
KIPS Closing of Public Offering of Common Stock, Including Exercise of Underwriters' Over-Allotment Option
KIPS break 0.76 and she goes
IDN I agree
IDN fingers crossed there aren't too many profit takers and they let her run.
IDN right on !
KIPS 0.745 slowly going higher
KIPS closing offering at 0.70 tomorrow
WAVX 2014 Could Be The Breakout Year For Wave Systems Corp.
http://seekingalpha.com/article/1970231-2014-could-be-the-breakout-year-for-wave-systems-corp?source=feed_f
RGDX receives $500,000 third GSK milestone payment
WAVX I can live with that
IDN I am patient . At some point she will run.
WAVX Bill Solms, CEO to Be Interviewed Live Today on Clear Channel Business Talk Radio DFW1190AM
IDN news Intellicheck Mobilisa Releases ID Scanning Product for Mexican Driver’s Licenses
Biiiig congrats
WAVX bought some
MSTX super stock
AEZS 1.39 from 1.30 buy
WAVX wie is Kris Goossens?
MSTX hope we can say bye bye to the pennies
IDN not staggering news but anything involving security is big these days
QTM news Quantum's New Deduplication Appliance Offers Best-in-Class Scalability, Density and Cost per TB With Pay-as-You-Grow Model
QTM the avg volume today, PPS barely moving, earnings next Wed. My next big mover? Hope so...
QTM E/R Jan 29; Expects Fiscal Third Quarter Revenue and Earnings Results to Exceed High End of Guidance
QTM buying on volume here. Storage Magazine Names Four Quantum Products as Product of the Year Awards Finalists, More Than Any Other Provider